Spirosure's Series C Round

Spirosure raised a round of funding on June 30, 2016.

Spirosure, fka Spirometix, creates breath-based diagnostic and monitoring devices with the aim to improve the lives of those with respiratory conditions like asthma, COPD, cystic fibrosis and pulmonar…

Articles about Spirosure's Series C Round: